Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2014; 20(18): 5527-5532
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5527
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5527
Table 2 Endoscopy-related outcomes among the groups n (%)
No sedation | Midazolam | Propofol | P value | |
(n = 35) | (n = 35) | (n = 33) | ||
Indications | 0.084 | |||
Screening | 28 (80.0) | 25 (71.4) | 17 (51.5) | |
Epigastric discomfort/pain | 5 (14.3) | 6 (17.2) | 14 (42.6) | |
Peptic ulcer disease follow-up | 1 (2.9) | 1 (2.9) | 2 (6.0) | |
Others | 1 (2.9) | 3 (8.6) | 0 (0.0) | |
Endoscopic findings | ||||
Reflux esophagitis | 4 (11.4) | 2 (5.7) | 2 (6.1) | 0.726 |
Hiatal hernia | 0 (0.0) | 3 (8.6) | 0 (0.0) | 0.105 |
Peptic ulcer disease | 3 (8.6) | 2 (5.7) | 2 (6.1) | 1.000 |
Gastric polyp | 2 (5.7) | 2 (5.7) | 1 (3.0) | 1.000 |
Neoplasm | 0 (0.0) | 2 (5.7) | 0 (0.0) | 0.327 |
Adverse event | ||||
Hiccoughing | 0 (0.0) | 9 (25.7) | 3 (90.0) | 0.002 |
Hypoxia | 0 (0.0) | 0 (0.0) | 2 (6.1) | 0.101 |
- Citation: Kim ES, Lee HY, Lee YJ, Min BR, Choi JH, Park KS, Cho KB, Jang BK, Chung WJ, Hwang JS. Negative impact of sedation on esophagogastric junction evaluation during esophagogastroduodenoscopy. World J Gastroenterol 2014; 20(18): 5527-5532
- URL: https://www.wjgnet.com/1007-9327/full/v20/i18/5527.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i18.5527